Prenatal SSRI use is linked to reduced head growth in study

03/5/2012 | Yahoo! · DailyRx.com

Babies born to mothers who took selective serotonin reuptake inhibitors were more likely to have reduced head growth, a Dutch study found. Mothers with untreated depression were more likely to give birth to babies with overall reduced growth. Researchers also found that mothers who used SSRIs had a higher risk of preterm birth compared with mothers without depression. The findings appear in the Archives of General Psychiatry.

View Full Article in:

Yahoo! · DailyRx.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC